[Antithrombotics in pre-hospital phase of acute coronary syndromes]

J P Collet1, R Dumaine, P Ecollan

  • 1Départment de Cardiogie, Institut de Cardiologie, Bureau. jean-philippe.collet@psl.ap-hop-paris.fr

Archives Des Maladies Du Coeur Et Des Vaisseaux
|December 29, 2005
PubMed

Insights

Prehospital initiation of antithrombotic therapies, including anticoagulation and GP IIb/IIIa inhibitors, is crucial for managing ST-elevation myocardial infarction (STEMI). Early administration of these treatments offers time-dependent benefits, improving patient outcomes.

Area of Science:

  • Cardiology
  • Pharmacology

Context:

  • Acute coronary syndrome (ACS) management relies heavily on antithrombotic therapies.
  • Prehospital care is increasingly recognized as a critical window for initiating these time-sensitive treatments.

Purpose:

  • To review the evidence supporting the prehospital initiation of antithrombotic therapies in ACS, particularly STEMI.
  • To evaluate the time-dependent benefits of anticoagulation, GP IIb/IIIa inhibitors, and clopidogrel.

Summary:

  • Anticoagulation therapy is validated as an effective, time-dependent treatment for STEMI.
  • GP IIb/IIIa receptor inhibitors are the preferred adjuvant therapy for primary PCI, reducing mortality.
  • Clopidogrel's efficacy is dose- and time-dependent, but prehospital benefit requires further establishment.

Impact:

  • Highlights the importance of early intervention in ACS for improved mortality.
  • Supports the integration of specific antithrombotic therapies into prehospital STEMI protocols.
  • Identifies areas for future research regarding prehospital clopidogrel administration.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...